Formosa Laboratories Inc (4746)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Formosa Laboratories Inc (4746) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013933
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Formosa Laboratories Inc (Formosa) is a healthcare products provider that develops ingredients. The company develops and markets active pharmaceutical ingredients and UV filters. Its active pharmaceutical ingredients comprise anticancers, cholesterol and phosphate binders, MRI enhancing agents, CNS agents, immunomodulators, anti-inflammatory and analgesic agents, respiratory agents, steroids, and other products. Formosa offers UV filters which include avobenzone, phenylbenzimidazole sulfonic acid used in sunscreens and cosmetics. The company also offers contract research and custom synthesis services such as process development, route optimization, purity assessment, analytical support and commercial production. Formosa is headquartered in Taoyuan, Taiwan.

Formosa Laboratories Inc (4746) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Formosa Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Formosa Labs to Form Joint Venture with YungShin Global and Sichuan Neijiang Huixin Pharma 10
Equity Offering 11
Formosa Labs Completes Public Offering Of Common Stock For US$1.67 Million 11
Formosa Labs Completes Rights Offering Of Common Stock For US$12.5 Million 12
Formosa Labs Raises Funds in IPO 13
Formosa Labs Completes Public Offering Of Common Stock For US$16 Million 14
Debt Offering 15
Formosa Labs to Raise up to USD16.5 Million in Public Offering of Bonds Due 2017 15
Formosa Labs Announces Public Offeiring Of Notes Due 2015 For US$16.8 Million 16
Acquisition 17
Formosa Labs to Acquire Activus Pharma from Sosei Group 17
Formosa Laboratories Inc – Key Competitors 18
Formosa Laboratories Inc – Key Employees 19
Formosa Laboratories Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Formosa Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Formosa Laboratories Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Formosa Labs to Form Joint Venture with YungShin Global and Sichuan Neijiang Huixin Pharma 10
Formosa Labs Completes Public Offering Of Common Stock For US$1.67 Million 11
Formosa Labs Completes Rights Offering Of Common Stock For US$12.5 Million 12
Formosa Labs Raises Funds in IPO 13
Formosa Labs Completes Public Offering Of Common Stock For US$16 Million 14
Formosa Labs to Raise up to USD16.5 Million in Public Offering of Bonds Due 2017 15
Formosa Labs Announces Public Offeiring Of Notes Due 2015 For US$16.8 Million 16
Formosa Labs to Acquire Activus Pharma from Sosei Group 17
Formosa Laboratories Inc, Key Competitors 18
Formosa Laboratories Inc, Key Employees 19

★海外企業調査レポート[Formosa Laboratories Inc (4746)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Paysafe Group Plc:企業の戦略的SWOT分析
    Paysafe Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • ConAgra Foods Inc:戦略・SWOT・企業財務分析
    ConAgra Foods Inc - Strategy, SWOT and Corporate Finance Report Summary ConAgra Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PPL Corp (PPL):企業の財務・戦略的SWOT分析
    PPL Corp (PPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Refresh Group Limited:企業の戦略・SWOT・財務情報
    Refresh Group Limited - Strategy, SWOT and Corporate Finance Report Summary Refresh Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Evotec AG (EVT):医療機器:M&Aディール及び事業提携情報
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • Premier Marketing Public Company Limited:戦略・SWOT・企業財務分析
    Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Protagen AG:企業のM&A・事業提携・投資動向
    Protagen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Protagen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • SSAB AB:企業の戦略・SWOT・財務情報
    SSAB AB - Strategy, SWOT and Corporate Finance Report Summary SSAB AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Octapharma AG:企業の戦略・SWOT・財務情報
    Octapharma AG - Strategy, SWOT and Corporate Finance Report Summary Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • J&P – Avax Sa:企業の戦略・SWOT・財務分析
    J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report Summary J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Chevron Corp (CVX):電力:M&Aディール及び事業提携情報
    Summary Chevron Corp (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for, produces and transports crude oi …
  • Mtr Corporation Ltd
    Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Alcon Inc (ALC):企業の財務・戦略的SWOT分析
    Alcon Inc (ALC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Henry Ford Health System:企業の戦略的SWOT分析
    Henry Ford Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Odakyu Electric Railway Co., Ltd. (9007):企業の財務・戦略的SWOT分析
    Odakyu Electric Railway Co., Ltd. (9007) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Airest S.p.A.:企業の戦略・SWOT・財務分析
    Airest S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Airest S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • A. H. Belo Corporation:企業のM&A・事業提携・投資動向
    A. H. Belo Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's A. H. Belo Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Disproquima S.A.:戦略・SWOT・企業財務分析
    Disproquima S.A. - Strategy, SWOT and Corporate Finance Report Summary Disproquima S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆